Positive predictive values of enzyme-linked immunosorbent assay (ELISA) for antienvoplakin and anticollagen VII antibodies: Results from 4 centers from Spain
- 28 October 2025
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (2) , 711-713
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Use of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experienceIndian Journal of Dermatology, Venereology and Leprology, 2024
- State-of-the-art diagnosis of autoimmune blistering diseasesFrontiers in Immunology, 2024
- S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)Journal of the European Academy of Dermatology and Venereology, 2023
- Clinical evaluation of a multiparametricELISAas a rapid tool for routinely diagnosing IgG‐mediated autoimmune blistering dermatoses in ethnic SlavsJournal of Clinical Laboratory Analysis, 2017
- Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseasesJournal of the American Academy of Dermatology, 2017